Date
16 November 2026
New report exposes gaps in affordable healthcare
Kusimba notes that access plans now cover 69% of late-stage pipeline candidates, more than three times the proportion in 2018, but that gaps remain in affordability, availability and reliable supply.Â
The article focuses on access challenges in cancer and diabetes care, including the uneven coverage of cancer access strategies across income groups and persistent barriers to insulin access. It also highlights the expansion of inclusive business models to 113 LMICs, while noting that limited product-level reporting makes it difficult to assess their reach. The article emphasises the need for stronger partnerships, business models adapted to local contexts and more transparent reporting on patient reach, particularly to ensure that progress in medicine development translates into treatment for underserved populations.Â
Access to Medicine Foundation CEO Jayasree K. Iyer is quoted: "Twenty years of progress have put us in a stronger position than ever to tackle persistent gaps on access," she said, urging companies to build on existing achievements. Director of Research Claudia MartÃnez also highlights that promising approaches remain concentrated among too few companies, products and disease areas, and calls for their wider adoption across the pharmaceutical industry.Â